Market Price Fluctuation Risk of Investment Securities
First written in FY2016. 23 of 35 entries say "Mitigated", first in FY2017-Q2. Latest entry: FY2026.
The whole theme swung hardest in 2019: 57 of 140 companies on the "Worse" side.
29 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Valuation difference on other securities 25,584」
The valuation difference on other securities increased by ¥25.584 million during the fiscal year, and the balance at fiscal year-end also increased from ¥267.282 million to ¥292.867 million. - 2026-05-13Cited as achievedRevision to earnings forecast
「投資有価証券売却益を特別利益に計上したこと」
アレンザホールディングス株式会社の株式をTOB参加により売却し、投資有価証券売却益を計上したことが、親会社株主に帰属する当期純利益の上方修正理由として示された。 - FY2026-H1MitigatedAnnual report
「Valuation difference on other securities 3,302 26,200」
The increase in the valuation difference on other securities expanded from ¥3.302 million in the same period of the previous year to ¥26.2 million, while valuation differences resulting from market price fluctuations continued to improve. - FY2025-H1Narrowing increase in valuation differenceAnnual report
「Valuation difference on other securities 27,956 3,302」
The valuation difference on other securities increased by ¥3.302 million in the interim consolidated accounting period, compared with an increase of ¥27.956 million in the same period of the previous year, resulting in a smaller increase. - FY2024MitigatedAnnual report
「Valuation difference on other securities 60,419」
The valuation difference on other securities increased by ¥60.419 million during the period, indicating an improving trend in valuation differences resulting from market price fluctuations. The company also recorded a ¥28.987 million gain on the sale of investment securities. - FY2024-Q3MitigatedAnnual report
「Valuation difference on other securities △ 939 30,855」
The valuation difference on other securities changed from a ¥939 thousand decrease in the same period of the previous year to a ¥30.855 million increase in the cumulative third quarter, indicating an improvement in the impact of valuation differences resulting from market price fluctuations. - FY2024-Q2MitigatedAnnual report
「Valuation difference on other securities 1,404 27,956」
The increase in the valuation difference on other securities expanded from ¥1.404 million in the same period of the previous year to ¥27.956 million, indicating an improving trend in the impact of valuation differences resulting from market price fluctuations. - FY2024-Q1MitigatedAnnual report
「Valuation difference on other securities 2,979 14,717」
The increase in the valuation difference on other securities expanded from ¥2.979 million in the same period of the previous year to ¥14.717 million, indicating an improving trend in the impact of valuation differences resulting from market price fluctuations. - FY2023-Q3MitigatedAnnual report
「Valuation difference on other securities △ 86,114 △ 939」
The decrease in the valuation difference on other securities was ¥939 thousand, down from a ¥86.114 million decrease in the same period of the previous year, indicating an improvement from the same period of the previous year in the impact of market price fluctuations. - FY2023-Q2MitigatedAnnual report
「Valuation difference on available-for-sale securities △ 63,484 1,404」
The valuation difference on other securities changed from a ¥63.484 million decrease in the same period of the previous year to a ¥1.404 million increase in the cumulative second quarter, indicating an improvement in the impact of valuation differences resulting from market price fluctuations. - FY2023-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities △ 83,452 2,979」
The valuation difference on available-for-sale securities changed from a decrease of ¥83.452 million in the same period of the previous fiscal year to an increase of ¥2.979 million in the current quarter, indicating an improvement year on year in the impact of market price fluctuations. - FY2022WorsenedAnnual report
「Although the valuation difference on available-for-sale securities decreased by ¥86 million」
The valuation difference on available-for-sale securities decreased by ¥86 million from the end of the previous fiscal year. Meanwhile, the company sold ¥231 million of investment securities and recorded a gain on sale of ¥123 million. - FY2022-Q3WorsenedAnnual report
「Although the valuation difference on available-for-sale securities decreased by ¥86 million」
The valuation difference on available-for-sale securities decreased by ¥86 million from the end of the previous consolidated fiscal year, with the impact of market price fluctuations appearing as a deterioration. - FY2022-Q2WorsenedAnnual report
「Although the valuation difference on available-for-sale securities decreased by ¥63 million」
The valuation difference on available-for-sale securities decreased from ¥265.483 million at the end of the previous consolidated fiscal year to ¥201.999 million, a decrease of ¥63 million, with the impact of market price fluctuations appearing as a deterioration. - FY2022-Q1WorsenedAnnual report
「The company recorded a ¥112 million gain on the sale of investment securities as extraordinary income in the current quarter, following the sale of some of its investment securities.」
While the company sold some investment securities, the valuation difference on available-for-sale securities decreased by ¥83 million, with the impact of market price fluctuations appearing as a reduction in the valuation difference during the current quarter. - FY2021MitigatedAnnual report
「Valuation difference on available-for-sale securities increased by ¥95 million」
The valuation difference on available-for-sale securities changed from negative in the previous fiscal year to a positive increase of ¥95 million in the current fiscal year, indicating an improvement in the impact of market price fluctuations. - FY2021-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities 20,128 74,035」
The increase in the valuation difference on available-for-sale securities for the cumulative third quarter was ¥74.035 million, exceeding the ¥20.128 million recorded in the same period of the previous fiscal year. The period-end balance was also positive at ¥243.815 million, indicating an improvement in valuation differences caused by market price fluctuations. - FY2021-Q2MitigatedAnnual report
「Valuation difference on available-for-sale securities △ 9,397 108,544」
The valuation difference on available-for-sale securities changed from negative ¥9.397 million in the same period of the previous fiscal year to positive ¥108.544 million, indicating an improvement in the impact of market price fluctuations. - FY2021-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities △ 1,783 51,347」
The valuation difference on available-for-sale securities changed from negative ¥1.783 million in the same period of the previous fiscal year to positive ¥51.347 million in the current quarter, indicating an improvement in the impact of market price fluctuations. - FY2020MitigatedAnnual report
「Valuation difference on available-for-sale securities △64,190」
The current-period valuation difference on available-for-sale securities was negative ¥64.190 million, with the extent of deterioration narrowing from negative ¥103.523 million in the previous fiscal year. - FY2020-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities △ 107,268 20,128」
The valuation difference on available-for-sale securities changed from negative ¥107.268 million in the same period of the previous fiscal year to positive ¥20.128 million for the cumulative current quarter, indicating an improvement in the impact of market price fluctuations. - FY2020-Q2WorsenedAnnual report
「Valuation difference on available-for-sale securities △ 9,397」
The valuation difference on available-for-sale securities was negative ¥9.397 million for the cumulative second quarter, worsening from negative ¥1.783 million in the previous quarter on a cumulative basis due to the impact of market price fluctuations. - FY2020-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities △ 1,783」
The negative valuation difference on available-for-sale securities narrowed from ¥20.541 million in the same period of the previous fiscal year to ¥1.783 million, indicating an improvement in the impact of market price fluctuations. - FY2019WorsenedAnnual report
「Valuation difference on available-for-sale securities △ 103,523」
The valuation difference on available-for-sale securities was negative ¥103.523 million on a current-period basis, with the impact of market price fluctuations reflected as a deterioration. - FY2019-Q3WorsenedAnnual report
「Valuation difference on available-for-sale securities △ 107,268」
The valuation difference on available-for-sale securities was negative ¥107.268 million, with the impact of market price fluctuations worsening profit or loss and comprehensive income. - FY2019-Q2MitigatedAnnual report
「Valuation difference on available-for-sale securities △ 5,411」
The negative valuation difference on available-for-sale securities narrowed from negative ¥20.541 million in the previous quarter, reducing the deterioration caused by market price fluctuations in the current quarter. - FY2019-Q1WorsenedAnnual report
「Valuation difference on available-for-sale securities △ 20,541」
The valuation difference on available-for-sale securities changed from positive ¥39.296 million in the same period of the previous fiscal year to negative ¥20.541 million, indicating a worsening impact from market price fluctuations. - FY2018-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities 356,840」
The valuation difference on available-for-sale securities was ¥356.840 million, up from ¥236.975 million at the end of the previous consolidated fiscal year. - FY2018-Q2MitigatedAnnual report
「Valuation difference on available-for-sale securities 304,519」
The valuation difference on available-for-sale securities was ¥304.519 million, up from ¥236.975 million at the end of the previous consolidated fiscal year. - FY2018-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities 39,296」
The valuation difference on available-for-sale securities in the first quarter was positive ¥39.296 million, improving from negative ¥24.297 million in the same period of the previous fiscal year. - FY2017MitigatedAnnual report
「Valuation difference on available-for-sale securities 236,975」
The valuation difference on available-for-sale securities was positive ¥236.975 million, up from ¥185.176 million at the end of the previous consolidated fiscal year. - FY2017-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities 220,060」
The valuation difference on available-for-sale securities was ¥220.060 million, up from ¥185.176 million at the end of the previous consolidated fiscal year. - FY2017-Q2MitigatedAnnual report
「Valuation difference on available-for-sale securities 194,241」
The valuation difference on available-for-sale securities changed from negative ¥24.297 million in the previous quarter to positive ¥194.241 million, eliminating the deterioration in valuation differences caused by market price fluctuations. - FY2017-Q1MaterialisedAnnual report
「Valuation difference on available-for-sale securities △ 24,297」
The valuation difference on available-for-sale securities was negative ¥24.297 million, quantifying the impact of market price fluctuations. - FY2016First statedAnnual report
「Equity securities classified as investment securities are exposed to market price fluctuation risk, but their fair values and financial condition are reviewed regularly.」
The fair values and financial condition of equity holdings, including specified equity securities held for investment purposes, are reviewed regularly.